Lantheus Holdings (LNTH) Deferred Taxes (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Deferred Taxes came in at $19.3 million in Q1 2026, up 1330.57% year-on-year from $1.4 million in Q1 2025, and up 1183.35% on a QoQ basis from -$1.8 million in Q4 2025.
Lantheus Holdings (LNTH) Deferred Taxes (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 12 years of Deferred Taxes data on file, last reported at $19.3 million in Q1 2026.
- On a quarterly basis, Deferred Taxes rose 1330.57% year-over-year to $19.3 million in Q1 2026; TTM through Mar 2026 was $39.6 million, a 199.08% increase from a year earlier, with the FY2025 full-year figure at $21.6 million, up 171.91% from the prior year.
- Deferred Taxes for Q1 2026 stood at $19.3 million, up from -$1.8 million in the prior quarter.
- Over the last five years, Deferred Taxes for LNTH reached as high as $29.0 million in Q3 2025 and fell as low as -$62.5 million in Q4 2022.
- Historically, Deferred Taxes has averaged -$5.5 million across 5 years, with a median of -$1.8 million in 2025.
- Across the five-year window, Deferred Taxes tumbled 1932.71% in 2022 and jumped 1330.57% in 2026, its largest moves.
- Year by year, Deferred Taxes stood at -$62.5 million in 2022, then soared by 103.23% to $2.0 million in 2023, then sank by 1370.55% to -$25.6 million in 2024, then soared by 93.04% to -$1.8 million in 2025, then jumped by 1183.35% to $19.3 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were $19.3 million in Q1 2026, -$1.8 million in Q4 2025, and $29.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 19.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.33 Mn |
| Dec 31, 2025 | -1.78 Mn |
| Sep 30, 2025 | 28.96 Mn |
| Jun 30, 2025 | -6.93 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | -25.63 Mn |
| Sep 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | -18.89 Mn |
| Mar 31, 2024 | 11.26 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | -18.03 Mn |
| Jun 30, 2023 | -3.75 Mn |
| Mar 31, 2023 | -35.86 Mn |
| Dec 31, 2022 | -62.48 Mn |
| Sep 30, 2022 | 7.86 Mn |
| Jun 30, 2022 | -7.58 Mn |
| Mar 31, 2022 | 14.18 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | -1.66 Mn |
| Jun 30, 2021 | -1.90 Mn |